LINC00865

Across TCGA pan-cancer cohorts, LINC00865 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC00865 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC00865 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00865 expression acts as an unfavorable survival marker, although some lineages such as UCS and LUAD show a favorable association.

STAD, UCS, and LGG are the cancer types where LINC00865 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.560	0.760	.003	62	view →
UCS	DFS	Quartile	III,IV	0.657	0.124	.001	54	view →
LGG	DFS	Tertile	All	0.296	0.471	<.001	38	view →
LUAD	OS	Median	All	0.489	0.280	.003	22	view →
THYM	OS	Median	II,III,IV	0.972	0.687	.008	20	view →
BLCA	OS	Tertile	II,III,IV	0.667	0.537	.017	17	view →
KIRP	DFS	Quartile	All	0.957	0.832	.006	14	view →
SKCM	OS	Quartile	All	0.378	0.253	.010	14	view →
KIRC	DFS	Tertile	IV	0.463	0.723	.005	12	view →
CHOL	DFS	Tertile	All	0.792	0.113	.007	12	view →
SARC	DFS	Median	All	0.643	0.438	.004	10	view →
ESCA	OS	Quartile	II,III,IV	1.000	0.381	.040	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC00865–STAD (OS)

Open the STAD breakdown →